RxDoctor Payments DataLook up a doctor →

Michael Song, MD

Neurological Surgery · Reno, NVNPI 1124067491

Payments from drug & device makers

$439,358in general payments, 2019–2025

Across 499 payments — averaging $880.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • 4web, Inc.$289K
  • Spineology Inc.$71K
  • Globus Medical$41K
  • Elliquence, LLC$10K
  • Integrity Implants Inc. Dba Accelus$10K
  • Abbott$5K
  • plus $13K from 22 others
$4,000in research payments, 2019–2025

Across 1 payment — averaging $4000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Spineology Inc.$4K

What the payments were for

  • Royalty or licence$26,07917%
  • Consulting fees$46,05030%
  • Speaking & faculty fees$38,40625%
  • Travel & lodging$27,64418%
  • Food & beverage$16,21010%
  • Gifts$440%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$439,358 in reported general payments places this provider in the 90th percentile of 45 neurological surgery providers in Nevada.

See all neurological surgery providers in Nevada

Medicare billing

Part B allowed, 2024
$361,578
Medicare patients
260
Services billed
818

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin13$92

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →